等待开盘 10-21 09:30:00 美东时间
+0.390
+1.87%
10月20-22日上海黄浦江畔,2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势,更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 05:10
今日重点评级关注:DA Davidson:维持美光科技"买入"评级,目标价从2100美元升至3000美元;Leerink Partners:维持OmniAb"跑赢大市"评级,目标价从10美元升至12美元
10-08 12:30
今日重点评级关注:Jones Trading:维持Opus Genetics"买入"评级,目标价从10美元升至17美元;Citizens:维持Rezolute"跑赢大市"评级,目标价从11美元升至15美元
10-07 17:30
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Goldman Sachs analyst Mark Delaney downgraded Gentex Corp (NASDAQ:GNTX) from Neutral to Sell and ...
10-06 21:12
Goldman Sachs analyst Mark Delaney downgrades Gentex (NASDAQ:GNTX) from Neutral to Sell and lowers the price target from $23 to $20.
10-06 17:26
Palm Valley Capital Fund outperformed with a return of 1.61% in Q3 2026, as compared to the S&P SmallCap 600 Index, which fell 7.93%, and the Morningstar Small-Cap Total Return Index, which declined 5...
10-05 21:10
Gentex (GNTX) declares $0.12/share quarterly dividend, in line with previous. Forward yield 2.12% Payable Oct. 21; for shareholders of record Oct. 7; ex-div Oct. 7. The company has now announced a div...
08-31 20:14
Gentex Corporation announced a quarterly cash dividend of $0.12 per share, payable on October 21, 2026, to shareholders of record as of October 7, 2026. The company, based in Zeeland, Michigan, specializes in digital vision, connected car technologies, dimmable glass, fire protection, medical devices, and consumer electronics.
08-31 12:00
今日重点评级关注:HC Wainwright & Co.:维持Innate Pharma"买入"评级,目标价从5美元升至7美元;HC Wainwright & Co.:维持Immix Biopharma"买入"评级,目标价从20美元升至25美元
08-11 11:45
JP Morgan analyst Rajat Gupta maintains Gentex (NASDAQ:GNTX) with a Neutral and lowers the price target from $28 to $27.
08-11 02:51